SEARCH RESULTS for GLAXOSMITHKLINE BIOLOGICALS SA

Recent Patent Assignments Patent Assignments - (Total found: 187)

Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame

(X0) 13822238: DEVELOPMENTS IN MENINGOCOCCAL OUTER MEMBRANE VESICLES

(A1) 20130236489: DEVELOPMENTS IN MENINGOCOCCAL OUTER MEMBRANE VESICLES

(B2) 9259462: DEVELOPMENTS IN MENINGOCOCCAL OUTER MEMBRANE VESICLES

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38982/874

(X0) 13994536: FLOW CYTOMETRY ANALYSIS OF MATERIALS ADSORBED TO METAL SALTS

(A1) 20130330840: FLOW CYTOMETRY ANALYSIS OF MATERIALS ADSORBED TO METAL SALTS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38982/913

(X0) 13820481: BACTERICIDAL ANTIBODY ASSAYS TO ASSESS IMMUNOGENICITY AND POTENCY OF MENINGOCOCCAL CAPSULAR SACCHARIDE VACCINES

(A1) 20130196352: BACTERICIDAL ANTIBODY ASSAYS TO ASSESS IMMUNOGENICITY AND POTENCY OF MENINGOCOCCAL CAPSULAR SACCHARIDE VACCINES

(B2) 9057716: BACTERICIDAL ANTIBODY ASSAYS TO ASSESS IMMUNOGENICITY AND POTENCY OF MENINGOCOCCAL CAPSULAR SACCHARIDE VACCINES

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38982/942

(X0) 13808087: DELIVERY OF RNA TO DIFFERENT CELL TYPES

(A1) 20130177640: DELIVERY OF RNA TO DIFFERENT CELL TYPES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38982/974

(X0) 13808080: LIPOSOMES WITH LIPIDS HAVING AN ADVANTAGEOUS PKA-VALUE FOR RNA DELIVERY

(A1) 20130171241: LIPOSOMES WITH LIPIDS HAVING AN ADVANTAGEOUS PKA-VALUE FOR RNA DELIVERY

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38983/4

7709009: IMMUNOGENIC COMPOSITIONS FOR STREPTOCOCCUS PYOGENES

8128936: IMMUNOGENIC COMPOSITIONS FOR STREPTOCOCCUS PYOGENES

8529913: IMMUNOGENIC COMPOSITIONS FOR STREPTOCOCCUS PYOGENES

9056912: IMMUNOGENIC COMPOSITIONS FOR STREPTOCOCCUS PYOGENES

NOVARTIS VACCINES AND DIAGNOSTICS INC

N/A

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38983/65

(X0) 13808085: DELIVERY OF RNA TO TRIGGER MULTIPLE IMMUNE PATHWAYS

(A1) 20130177639: DELIVERY OF RNA TO TRIGGER MULTIPLE IMMUNE PATHWAYS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38983/509

(X0) 14005525: ADJUVANT NANOEMULSIONS WITH PHOSPHOLIPIDS

(A1) 20140017285: ADJUVANT NANOEMULSIONS WITH PHOSPHOLIPIDS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38983/585

9192661: DELIVERY OF SELF-REPLICATING RNA USING BIODEGRADABLE POLYMER PARTICLES

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38983/634

(X0) 13637929: IMMUNOGENIC PROTEINS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF STREPTOCOCCUS AGALACTIAE

(A1) 20130071416: IMMUNOGENIC PROTEINS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF STREPTOCOCCUS AGALACTIAE

(B2) 9079946: IMMUNOGENIC PROTEINS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF STREPTOCOCCUS AGALACTIAE

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38983/781

(X0) 13520338: POLYSACCHARIDE IMMUNOGENS CONJUGATED TO E. COLI CARRIER PROTEINS

(A1) 20120308600: POLYSACCHARIDE IMMUNOGENS CONJUGATED TO E. COLI CARRIER PROTEINS

(B2) 9173954: POLYSACCHARIDE IMMUNOGENS CONJUGATED TO E. COLI CARRIER PROTEINS

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38983/849

9125864: OMV VACCINES

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38983/886

(X0) 13394036: COMPOUNDS AND COMPOSITIONS AS TLR ACTIVITY MODULATORS

(A1) 20120237546: COMPOUNDS AND COMPOSITIONS AS TLR ACTIVITY MODULATORS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38983/909

(X0) 13377511: BENZONAPHTHYRIDINE-CONTAINING VACCINES

(A1) 20120263753: BENZONAPHTHYRIDINE-CONTAINING VACCINES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38983/980

(X0) 13504920: PURIFICATION OF STAPHYLOCOCCUS AUREUS TYPE 5 CAPSULAR SACCHARIDES

(A1) 20120282295: PURIFICATION OF STAPHYLOCOCCUS AUREUS TYPE 5 CAPSULAR SACCHARIDES

(B2) 9060965: PURIFICATION OF STAPHYLOCOCCUS AUREUS TYPE 5 CAPSULAR SACCHARIDES

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38984/61

8974799: CONJUGATION OF STAPHYLOCOCCUS AUREUS TYPE 5 AND TYPE 8 CAPSULAR POLYSACCHARIDES

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38984/93

8871214: DETOXIFIED ESCHERICHIA COLI IMMUNOGENS

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38984/138

9151756: CHLAMYDIA ANTIGENS

8568732: CHLAMYDIA ANTIGENS

NOVARTIS AG

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38984/187

(X0) 13139043: MIXING LYOPHILISED MENINGOCOCCAL VACCINES WITH NON-HIB VACCINES

(A1) 20110311576: MIXING LYOPHILISED MENINGOCOCCAL VACCINES WITH NON-HIB VACCINES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38984/224

(X0) 13260548: COMBINATIONS OF MENINGOCOCCAL FACTOR H BINDING PROTEIN AND PNEUMOCOCCAL SACCHARIDE CONJUGATES

(A1) 20120064103: COMBINATIONS OF MENINGOCOCCAL FACTOR H BINDING PROTEIN AND PNEUMOCOCCAL SACCHARIDE CONJUGATES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38984/282

(X0) 14307001: ADJUVANTING MENINGOCOCCAL FACTOR H BINDING PROTEIN

(A1) 20140294887: ADJUVANTING MENINGOCOCCAL FACTOR H BINDING PROTEIN

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38984/367

(X0) 12744878: An RNA expression cassette and cells for making alphavirus particles

(A1) 20110207223: An RNA expression cassette and cells for making alphavirus particles

(B2) 9234181: An RNA expression cassette and cells for making alphavirus particles

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38984/407

(X0) 12990110: NANOPARTICLES FOR USE IN PHARMACEUTICAL COMPOSITIONS

(A1) 20110038900: NANOPARTICLES FOR USE IN PHARMACEUTICAL COMPOSITIONS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38984/779

7731978: MUTANT FORMS OF STREPTOLYSIN O

8409589: MUTANT FORMS OF STREPTOLYSIN O

8039005: MUTANT FORMS OF STREPTOLYSIN O

NOVARTIS AG

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38984/859

(X0) 12746723: COMPOSITIONS FOR INDUCING IMMUNE RESPONSES

(A1) 20110135679: COMPOSITIONS FOR INDUCING IMMUNE RESPONSES

(B2) 8815253: COMPOSITIONS FOR INDUCING IMMUNE RESPONSES

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38984/920

(X0) 14335612: MICROPARTICLES FOR USE IN IMMUNOGENIC COMPOSITIONS

(A1) 20150017251: MICROPARTICLES FOR USE IN IMMUNOGENIC COMPOSITIONS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38984/943

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38985/1

(X0) 12747914: FERMENTATION PROCESSES FOR CULTIVATING STREPTOCOCCI AND PURIFICATION PROCESSES FOR OBTAINING CPS THEREFROM

(A1) 20100272755: FERMENTATION PROCESSES FOR CULTIVATING STREPTOCOCCI AND PURIFICATION PROCESSES FOR OBTAINING CPS THEREFROM

(B2) 8445239: FERMENTATION PROCESSES FOR CULTIVATING STREPTOCOCCI AND PURIFICATION PROCESSES FOR OBTAINING CPS THEREFROM

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38985/59

(X0) 12734796: ADJUVANTED GLUCANS

(A1) 20100266626: ADJUVANTED GLUCANS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38985/114

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38985/142

8287885: GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES

8858957: GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES

9102741: GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES

8399651: NUCLEIC ACIDS ENCODING GAS57 MUTANT ANTIGENS

NOVARTIS AG

N/A

N/A

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38985/214

8470341: ESCHERICHIA COLI IMMUNOGENS WITH IMPROVED SOLUBILITY

9101560: ESCHERICHIA COLI IMMUNOGENS WITH IMPROVED SOLUBILITY

NOVARTIS AG

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38985/306

(X0) 12669464: CONJUGATE PURIFICATION

(A1) 20100239600: CONJUGATE PURIFICATION

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38985/345

(X0) 12744306: LIPOPOLYSACCHARIDE DECONTAMINATION

(A1) 20100282684: LIPOPOLYSACCHARIDE DECONTAMINATION

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38985/363

(X0) 12451831: FORMULATION OF MENINGITIS VACCINES

(A1) 20100203137: FORMULATION OF MENINGITIS VACCINES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38985/406

(X0) 13139021: MIXING LYOPHILISED MENINGOCOCCAL VACCINES WITH D-T-Pa VACCINES

(A1) 20110311575: MIXING LYOPHILISED MENINGOCOCCAL VACCINES WITH D-T-Pa VACCINES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38985/458

(X0) 12095655: Nanoparticles For Use In Immunogenic Compositions

(A1) 20100285135: Nanoparticles For Use In Immunogenic Compositions

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38985/486

9180204: Liquid Vaccines For Multiple Meningococcal Serogroups

8765135: Liquid Vaccines For Multiple Meningococcal Serogroups

NOVARTIS AG

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38985/536

(X0) 14267248: HYPO- AND HYPER-ACETYLATED MENINGOCOCCAL CAPSULAR SACCHARIDES

(A1) 20140234368: HYPO- AND HYPER-ACETYLATED MENINGOCOCCAL CAPSULAR SACCHARIDES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38985/594

(X0) 11587189: Immunising Against Meningococcal Serogroup Y Using Proteins

(A1) 20100143418: Immunising Against Meningococcal Serogroup Y Using Proteins

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38985/696

(X0) 12083905: Multiclade HIV Vaccines

(A1) 20110110977: Multiclade HIV Vaccines

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38985/742

(X0) 12448709: MODIFIED SACCHARIDES

(A1) 20100322958: MODIFIED SACCHARIDES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38985/772

8529908: MENINGOCOCCAL CONJUGATE VACCINATION

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38985/818

9315530: ADSORPTION OF IMMUNOPOTENTIATORS TO INSOLUBLE METAL SALTS

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

38985/844

(X0) 14420238: COMBINATION VACCINES WITH SEROGROUP B MENINGOCOCCUS AND D/T/P

(A1) 20150190493: COMBINATION VACCINES WITH SEROGROUP B MENINGOCOCCUS AND D/T/P

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38985/903

(X0) 14424362: IMMUNOGENIC COMPOSITIONS

(A1) 20150224185: IMMUNOGENIC COMPOSITIONS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38985/936

(X0) 14424839: OUTER MEMBRANE VESICLES

(A1) 20150231232: OUTER MEMBRANE VESICLES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38985/992

(X0) 14420831: STABILISED PROTEINS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS

(A1) 20150203542: STABILISED PROTEINS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38986/13

(X0) 14382690: IN VITRO POTENCY ASSAY FOR PROTEIN-BASED MENINGOCOCCAL VACCINES

(A1) 20150301051: IN VITRO POTENCY ASSAY FOR PROTEIN-BASED MENINGOCOCCAL VACCINES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38986/72

(X0) 14381090: ADJUVANTED FORMULATIONS OF STREPTOCOCCUS PNEUMONIAE ANTIGENS

(A1) 20150132339: ADJUVANTED FORMULATIONS OF STREPTOCOCCUS PNEUMONIAE ANTIGENS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38986/106